Why Is The Mesoblast (MESO) Stock Rising In Pre-Hours Trading?
The shares of global leader in allogeneic cellular medicines for inflammatory diseases, Mesoblast Limited (NASDAQ: MESO) are rising on the charts today, up 10.80% to $8.00 at last check-in premarket trades. Mesoblast stock closed Thursday session at $7.22, falling -1.37%. The volume for MESO stock was 0.48 million, compared to 281.32K daily average. For positive […]
